[PDF][PDF] Targeted inactivation of Mdm2 RING finger E3 ubiquitin ligase activity in the mouse reveals mechanistic insights into p53 regulation

K Itahana, H Mao, A Jin, Y Itahana, HV Clegg… - Cancer cell, 2007 - cell.com
K Itahana, H Mao, A Jin, Y Itahana, HV Clegg, MS Lindström, KP Bhat, VL Godfrey, GI Evan
Cancer cell, 2007cell.com
It is believed that Mdm2 suppresses p53 in two ways: transcriptional inhibition by direct
binding, and degradation via its E3 ligase activity. To study these functions physiologically,
we generated mice bearing a single-residue substitution (C462A) abolishing the E3 function
without affecting p53 binding. Unexpectedly, homozygous mutant mice died before E7. 5,
and deletion of p53 rescued the lethality. Furthermore, reintroducing a switchable p53 by
crossing with p53ER TAM mice surprisingly demonstrated that the mutant Mdm2 C462A was …
Summary
It is believed that Mdm2 suppresses p53 in two ways: transcriptional inhibition by direct binding, and degradation via its E3 ligase activity. To study these functions physiologically, we generated mice bearing a single-residue substitution (C462A) abolishing the E3 function without affecting p53 binding. Unexpectedly, homozygous mutant mice died before E7.5, and deletion of p53 rescued the lethality. Furthermore, reintroducing a switchable p53 by crossing with p53ERTAM mice surprisingly demonstrated that the mutant Mdm2C462A was rapidly degraded in a manner indistinguishable from that of the wild-type Mdm2. Hence, our data indicate that (1) the Mdm2-p53 physical interaction, without Mdm2-mediated p53 ubiquitination, cannot control p53 activity sufficiently to allow early mouse embryonic development, and (2) Mdm2's E3 function is not required for Mdm2 degradation.
cell.com